Many experts were impressed when General Electric Co. ponied up $587 million to acquire pathology testing company Clarient, Inc., in October 2010. Now comes further insight behind this transaction. At an investment conference in Boston on November 3, John Dineen, CEO of GE Healthcare, told the audience that his company—currently generating revenue of $2.4 billion …
November 7, 2011 “Intelligence: Late Breaking Lab News” Read More »
